Science Market Update

$3.2M Granted to UGA for Vaccine Research

Posted by Laura Braden on Wed, Oct 11, 2017

Vaccine research is a field that is constantly growing and changing, from new vaccines being created to different vaccination methods being developed. With diseases changing and new diseases emerging, researchers around the world work tirelessly to create treatments. Researchers from the College of Veterinary Medicine at the University of Georgia, Athens recently received a grant of $3.2 million from the National Institutes of Health (NIH) to continue their work developing new vaccine platforms. (Image courtesy of John Keith via Wikimedia Commons)

Read More

Tags: University of Georgia Athens, vaccine research, UGA, BioResearch Product Faire Event, NIH funding, NIH grant, 2018, SAAVE

$8M Granted to UCLA to Study Cytomegalovirus and Kidney Transplants

Posted by Laura Braden on Thu, Oct 05, 2017

Organ transplants are common surgeries that happen around the world. In the United States, more than 33,000 transplants occurred in 2016, with more than half of these being kidney transplants. Although the majority of people come out of transplant surgery with no problems, many develop serious infections caused by the common virus cytomegalovirus (CMV)when the immune system rejects the new kidney.

Read More

Tags: CA, new research funding, LAVS, UCLA, Biotechnology Vendor Showcase, NIH funding, 2017, cytomegalovirus

$11.5M Granted to Houston Scientists for Lymphoma Treatment Research

Posted by Laura Braden on Wed, Oct 04, 2017

Lymphoma is one of the most common types of cancer, with Non-Hodgkin Lymphoma making up about 4% of all cancer cases in the United States, according to the American Cancer Society. Although treatment methods like chemotherapy and radiation therapy are able to treat the cancer, researchers still actively study this cancer to gain a better understanding of it to develop new targeted treatment methods. 

Researchers from the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital have been studying new therapies for the cancer using T-cells, research that they will continue with the assistance of a new $11.5 million grant from the National Cancer Institute. (Image courtesy of TexasPathologistMSW ia Wikimedia Commons)

Read More

Tags: new research funding, cancer research, Texas Medical Center, tmc, Houston, TX, NIH funding, 2018, Lymphoma, Baylor College of Medicine

University of Arizona Granted $4.8M for Valley Fever Vaccine Research

Posted by Laura Braden on Thu, Sep 28, 2017

Valley Fever affects nearly 10,000 people in the United States each year, predominately in the Southwestern states of Arizona and California. This infection, caused by the fungus Coccidioide, affects different people in different ways: some get very ill while others are only mildly affected. However people are affected, there is no vaccine to cure the infection. A team of researchers from the University of Arizona, Tucson recently received a $4.8 million grant from the National Institute of Allergy and Infectious Disease (NIAID) to develop a vaccine for Valley Fever. 

Read More

Tags: new research funding, AZ, UAZ, BioResearch Product Faire Event, Tucson, NIH funding, University of Arizona Tucson, 2017, Valley Fever

UAB Center for AIDS Research Committed to Stopping HIV by 2030

Posted by Rebecca Partridge on Tue, Aug 22, 2017

According to an article for UAB News, 40% of individuals infected with HIV are not currently receiving antiretroviral therapy, which means their disease is not suppressed. The University of Alabama, Birmingham’s Center for AIDS Research recently partnered with state and local agencies in signing the Paris Declaration to eliminate the spread of HIV/AIDS by 2030. Birmingham is the 13th U.S. city to commit to achieving the Declaration’s goals.

Read More

Tags: Bioresearch funding, AIDS Research, Alabama, University of Alabama, University of Alabama Birmingham, UAlab, UAB, NIH funding, University of Alabama at Birmingham, BioResearch Product Faire, Bioresearch Grant, NIH awards 2017

UC Irvine: $9.6M in NIAID Research Funding for Malaria Study

Posted by Rebecca Partridge on Thu, Jun 22, 2017

The National Institute of Allergy & Infectious Diseases (NIAID) awarded University of California, Irvine $9.6 million to study the impact of environmental changes on malaria in sub-Saharan Africa. This research funding establishes UCI as one of the International Centers of Excellence for Malaria Research (ICEMR).

Read More

Tags: University of California Irvine, malaria, Research Funding, Laboratory Equipment Supplier, Lab Product Sales, NIH funding, UCI, UC Irvine, BioResearch Product Faire, 2017 research funding

$577M in Biomedical Research Funding Makes UCSF Top NIH Recipient

Posted by Rebecca Partridge on Mon, May 08, 2017

For the sixth year in a row, UC San Francisco was the top public recipient of biomedical research grants from the National Institutes of Health (NIH). Overall, UCSF researchers were awarded $577.6 million in NIH grants and contracts in 2016. This was a 3 percent increase over 2015, which is consistent with UCSF’s average annual increase over the past five years.

(Image courtesy of Wikimedia Commons)

Read More

Tags: University of California San Francisco, sell lab products, Research Funding, UCSF, Lab Product Sales, NIH funding, UC San Francisco Parnassus, BioResearch Product Faire, NIH awards 2017

UCLA: Nearly $9M in NHLBI Funding to Help Take Science Solutions to Heart

Posted by Rebecca Partridge on Wed, Mar 15, 2017

Thus far in 2017, the University of California Los Angeles has received over $6.8 million in funding from the National Heart Lung and Blood Institute (NHLBI). This funding has been awarded through multiple grants intended to support cardiovascular research.

Read More

Tags: University of California Los Angeles, cardiovascular research, increase laboratory product sales, UCLA, NIH funding, life science research at UCLA, life science solutions, science solutions, NIH awards 2017

$8M Granted to Irvine Researchers for Q Fever Vaccine

Posted by Laura Braden on Fri, May 27, 2016


Q fever, an infectious disease caused by the bacteria Coxiella burnetii, is common among livestock such as cattle, sheep and goats. The bacteria can be transmitted to humans through the inhalation of barnyard dust that is contaminated with animal excretion containing the bacteria. Along with passing from livestock to humans, Q fever has been aerosolized in the past and used for biological warfare.

(Image Courtest of Wikimedia Commons and the National Institutes of Health)

Read More

Tags: CA, vaccine research, infectious diseases, NIH funding, UCI, UC Irvine, 2016, BioResearch Product Faire, Western, Coxiella burnetii, Q Fever

WUSTL Receives $60M to Research the Genetics of Common Diseases

Posted by Laura Braden on Fri, Feb 19, 2016

The National Institutes of Health (NIH) recently launched a new network of institutions - called the Centers for Common Disease Genomics (CCDG) - which will study common conditions such as heart disease, stroke, diabetes, and autism to see how genetics and DNA contribute to the risk of these diseases. The McDonnell Genome Institute at Washington University in St. Louis is one of four institutions involved in this network and will be receiving $60 million over the next four years to study genomics and common diseases.    

Read More

Tags: Washington University St. Louis, Midwest, Missouri, WashU, heart disease, Diabetes, Autism, BioResearch Product Faire Event, MO, St Louis, NIH funding, 2016, Centers for Common Disease Genomics, stroke, CCDG

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News